Top Stories
-
There is a robust market for books that praise our seemingly feeble habits of mind.
Topic
-
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
Topic
-
After exercising, choose a brain-healthy recovery meal.
Topic
-
Source:
CUIMC NewsroomA new study on COVID-19 patients with dementia led by James Noble, MD, MS associate professor of neurology at CUIMC
Topic
